Avantor Investor Day Presentation Deck

and win specifications on commercialized platforms DISCOVERY PIPELINE RESEARCH & DISCOVERY O e Source: Evaluate Pharma, top biologics of 2022. DEVELOPMENT & SCALE-UP ~90% D 874 PRODUCTION of self-manufactured production content is spec'd in to customers' products or processes BIOLOGICS EXAMPLE Content on STRONG POSITION % of top 20 biologics Exposure to all modalities & treatment areas, including mAbs, Cell & Gene Therapy, GLP-1s & mRNA Navantor™ 13

View entire presentation